Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-21: Form 6-K; Period of report 2022-12-21; Description FORM 6-K; Document form6k_122122.htm.
- 2022-12-13: Form 6-K; Period of report 2022-12-13; Description FORM 6-K; Document form6k_121322.htm.
- 2022-12-08: Form 6-K; Period of report 2022-12-08; Description FORM 6-K; Document form6k_120822.htm.
- 2022-11-30: Form 6-K; Period of report 2022-11-30; Description FORM 6-K; Document form6k_113022.htm.